SECsense Logo

Crinetics Pharmaceuticals 8-K Filing Report - Key Insights & Updates

$CRNX
Form 8-K
Filed on: 2025-01-10
Source
Crinetics Pharmaceuticals 8-K Filing Report - Key Insights & Updates

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Crinetics Pharmaceuticals, Inc.
  • CIK Number: 0001658247
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-38583
  • Employer Identification Number (EIN): 26-3744114
  1. Address and Contact:
  • Headquarters: 6055 Lusk Boulevard, San Diego, CA 92121
  • Phone Number: (858) 450-6464
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: CRNX
  • Exchange: NASDAQ
  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: January 10, 2025
  • Period Covered: The filing pertains to events that occurred on the same date, January 10, 2025.
  1. XML/XBRL Details:
  • This section is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for filing financial reports with the SEC.

Summary

This report indicates that Crinetics Pharmaceuticals, Inc. filed an 8-K on January 10, 2025. The filing likely contains important corporate news or events that occurred on that date. Key identifiers such as the CIK number and SEC file number are provided for reference, along with the company’s stock details. The use of XBRL suggests this is part of a standardized reporting process for better data interoperability.